InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (15 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
15
T+90 hit rate
0%
T+90 mean return
-48.5%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by DiBiase Mary, Chief Operating Officer. Insider active across 1 company, notably X4 Pharmaceuticals, Inc. Aggregated, 22 filings have been recorded. Split: 0 buy · 15 sells. Total volume traded: €90k. History available since 8 September 2021. The latest transaction was disclosed on 12 February 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations22 total
650,000 shares0Common StockSEC:0001628280-25-005696:0
61,178 shares0Common StockSEC:0001628280-25-002706:0
230,645 shares0Common StockSEC:0001628280-24-042542:0
2,642 shares@ US$0.65771.8% of flowCommon StockSEC:0001628280-24-040128:0
15,409 shares@ US$0.88213.9% of flowCommon StockSEC:0001628280-24-010278:0
3,683 shares@ US$1.0073.8% of flowCommon StockSEC:0001628280-24-004288:0
67,695 shares@ US$0.7352.2% of flowCommon StockSEC:0001628280-23-036757:0
230,645 shares0Common StockSEC:0001628280-23-036459:0
2,642 shares@ US$1.2493.4% of flowCommon StockSEC:0001628280-23-032065:0
464 shares@ US$1.890.9% of flowCommon StockSEC:0001628280-23-024229:0
857 shares@ US$1.931.7% of flowCommon StockSEC:0001628280-23-023445:0
857 shares@ US$2.232.0% of flowCommon StockSEC:0001628280-23-022480:0
18,192 shares@ US$0.8416.1% of flowCommon StockSEC:0001628280-23-007724:0
4,348 shares@ US$0.934.2% of flowCommon StockSEC:0001628280-23-003758:0
1,713 sharesCommon StockSEC:0001628280-22-023325:0
1,578 sharesCommon StockSEC:0001628280-22-018397:0
856 sharesCommon StockSEC:0001628280-22-018044:0
856 sharesCommon StockSEC:0001628280-22-017435:0
105,000 shares0Common StockSEC:0001628280-22-004518:0
12,545 sharesCommon StockSEC:0001628280-22-002508:0
27,000 shares0Common StockSEC:0001628280-21-018385:0
27,000 shares0Common StockSEC:0001628280-21-018385
22 of 22 declarations
About DiBiase Mary
DiBiase Mary is the Chief Operating Officer at X4 Pharmaceuticals, Inc. She oversees the daily operations of the company, ensuring efficiency and implementation of operational strategies. Mary plays a key role in optimizing processes and managing resources, thereby contributing to the overall performance of the company. Her expertise in operational management is essential for the success of X4 Pharmaceuticals.
